Recombinant protein expression for therapeutic applications

Current Opinion in Biotechnology

Volumn 13, Issue 2, 2002, Pages 117-123

  Andersen, Dana C ^a   Krummen, Lynne ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOPROTEIN; RECOMBINANT PROTEIN;

CELL CULTURE; DRUG SYNTHESIS; GENE EXPRESSION SYSTEM; MAMMAL; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVIEW;

MAMMALIA; NEGIBACTERIA;

EID: 0036535753     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(02)00300-2     Document Type: Review

References (96)

1. Industrial choices for protein production by large-scale cell culture
2. Advances in Escherichia coli production of therapeutic proteins
3. Therapeutic antibody expression technology
4. IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines
5. Rapid establishment of high-producing cell lines using dicistronic vectors with glutamine synthase as the selection marker
6. Stabilized, long-term expression of heterodimeric proteins from tricistronic mRNA
7. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs
8. High level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector
9. Appropriate mammalian expression systems for biopharmaceuticals
10. Development of stable cell lines for production or regulated expression using matrix attachment regions
11. The impact of mammalian gene regulation concepts on functional genomics research, metabolic engineering, and advanced gene therapies
12. Streptogramin-based gene regulation systems for mammalian cells
13. Streptogramin- and tetracycline-responsive dual regulated expression of p27(Kip1) sense and antisense enables positive and negative growth control of Chinese hamster ovary cells
14. A high-throughput alphavirus-based expression cloning system for mammalian cells
15. Transient gene expression: Recombinant protein production with suspension-adapted HEK293-EBNA cells
16. The oligosaccharides of glycoproteins: Bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties
17. Getting the glycosylation right: Implications for the biotechnology industry
18. Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells
19. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins
20. Engineering glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
21. Expression of GnTIII in recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FcγRIII
22. Construction of stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(β1-4)GlcNAc-R α2,6-sialyltransferase
23. Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ
24. Improvement of primary metabolisms of cell cultures by introducing a new cytoplasmic pyruvate carboxylase reaction
25. Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody production
26. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells
27. Comparative analysis of two controlled proliferation strategies regarding product quality, influence on tetracycline-regulated gene expression, and productivity
28. Proliferation control of mammalian cells by the tumor suppressor IRF-1
29. Enhanced productivity during controlled proliferation of BHK cells in continuously perfused bioreactors
30. A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: Effect of nutrient concentration, dilution rate and pH
31. The effect of dilution rate on CHO cell physiology and recombinant interferon-γ production in glucose-limited chemostat culture
32. Engineering Chinese hamster ovary (CHO) cells to achieve an inverse growth-associated production of a foreign protein, β-galactosidase
33. Part II. Overexpression of Bcl-2 family members enhances survival of mammalian cells in response to various culture insults
34. Understanding and modulating apoptosis in industrial cell culture
35. Overexpression of Bcl-2 inhibits sodium butyrate-induced apoptosis in Chinese hamster ovary cells resulting in enhanced humanized antibody production
36. Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults
37. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells
38. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells
39. Phosphate feeding improves high cell concentration NS0 myeloma culture performance for monoclonal antibody production
40. N-Acetylcysteine increases the biosynthesis of recombinant EPO in apoptotic Chinese hamster ovary cells
41. Serum protects protein-free competent Chinese hamster ovary cells against apoptosis induced by nutrient deprivation in batch culture
42. Rapamycin reduces hybridoma cell death and enhances monoclonal antibody production
43. Recombinant protein expression in Escherichia coli
44. A temperature-driven switch from chaperone to protease in a widely conserved heat shock protein
45. DegP-coexpression minimizes inclusion-body formation upon overproduction of recombinant penicillin amylase in Escherichia coli
46. Effect of sequences of the active-site dipeptides of DsbA and DsbC on in vivo folding of multidisulfide proteins in Escherichia coli
47. Overexpression of Escherichia coli oxidoreductases increases recombinant insulin-like growth factor-I accumulation
48. The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA
49. Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones
50. ClpB and HtpG facilitate de novo protein folding in stressed Escherichia coli cells
51. Coordinated, differential expression of two genes through directed mRNA cleavage and stabilization by secondary structures
52. Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli
53. Regulatable arabinose-inducible gene expression system with consistent control in all cells of a culture
54. Characterization of an oxygen-dependent inducible promoter, the nar promoter of Escherichia coli, to utilize in metabolic engineering
55. High-cell-density fermentation for production of L-N-carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter
56. Avoiding acetate accumulation in Escherichia coli cultures using feedback control of glucose feeding
57. Cell growth and by-product formation in a pyruvate kinase mutant of E. coli
58. Error-prone PCR of Vitreoscilla hemoglobin (VHb) to support the growth of microaerobic Escherichia coli
59. Novel hemoglobins to enhance microaerobic growth and substrate utilization in Escherichia coli
60. Nitrite inhibition of Vitreoscilla hemoglobin (VHb) in recombinant E. coli: Direct evidence that VHb enhances recombinant protein production
61. Dissection of central carbon metabolism of hemoglobin-expressing Escherichia coli by 13C nuclear magnetic resonance flux distribution analysis in microaerobic bioprocesses
62. DNA microarray detection of metabolic responses to protein overproduction in Escherichia coli
63. Kinetics of heat-shock response and inclusion body formation during temperature-induced production of basic fibroblast growth factor in high-cell-density cultures of recombinant Escherichia coli
64. Genomic analysis of high-cell-density recombinant Escherichia coli fermentation and "cell conditioning" for improved recombinant protein and "cell conditioning" for improved recombinant protein yield
65. Effects of FIS overexpression on cell growth, rRNA synthesis, and ribosome content in Escherichia coli
66. DNA microarray-based identification of genes controlled by autoinducer 2-stimulated quorum sensing in Escherichia coli
67. Metabolic oscillations in an E. coli fermentation
68. Co-overexpression of RspAB improves recombinant protein production in Escherichia coli
69. Towards the development of a minimal cell model by generalization of a model of Escherichia coli: Use of dimensionless rate parameters
70. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data
71. Kinetic model of in vivo folding and inclusion body formation in recombinant Escherichia coli
72. Stochastic kinetic analysis of the Escherichia coli stress circuit using σ32-targeted antisense
73. Transgenic plants as factories for biopharmaceuticals
74. Foreign protein production in plant tissue cultures
75. Producing proteins in transgenic plant and animals
76. Characterization of monoclonal antibody fragments produced by plant cells
77. Glycoproteins from insect cells: Sialylated or not?
78. N-Glycan patterns of human transferrin produced in Trichoplusiani insect cells: Effects of mammalian glycosyltransferase
79. Improved glycosylation of a foreign protein by Tn-5B1-4 cells engineered to express mammalian glycosyltransferases
80. Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopteran insect cells
81. Production of sialylated N-linked glycoproteins in insect cells
82. Determination of nucleotides involved in protein glycosylation by high-performance anion-exchange chromatography: Sugar nucleotide contents in cultured insect cells and mammalian cells
83. High-level expression and stabilization of recombinant human chitinase produced in a continuous constitutive Pichia pastoris expression system
84. Human insulin from a precursor overexpressed in the methylotrophic yeast Pichia pastoris and a simple procedure for purifying the expression product
85. A rational approach to improving productivity in recombinant Pichia pastoris fermentation
86. Analysis of a single-chain antibody production in Pichia pastoris using on-line methanol control in fed-batch and mixed-feed fermentations
87. Cell-cycle-dependent protein secretion by Saccharomyces cerevisiae
88. The metabolic burden of the PGK1 and ADH2 promoter systems for heterologous xylanase production by Saccharomyces cerevisiae in defined medium
89. Regeneration of adenosine triphosphate from glycolytic intermediates for cell-free protein synthesis
90. Cell-free translation reconstituted with purified components
91. Programmed Escherichia coli cell lysis by expression of cloned T4 phage lysis genes
92. Human chymotrypsin B production with Pichia pastoris by integrated development of fermentation and downstream processing. Part 1. Fermentation
93. Human chymotrypsin B production from Pichia pastoris by integrated development of fermentation and downstream processing. Part 2. Protein recovery
94. Choline-binding domain as a novel affinity tag for purification of fusion proteins produced in Pichia pastoris